2 weeks ago

Brilliance Cosmocare Raises $200,000 Seed Round for Longevity Skin Platform

Brilliance Cosmocare Raises $200,000 Seed Round for Longevity Skin Platform
Mumbai’s Brilliance Cosmocare Raises $200,000 Seed Round to Build India’s First Doctor-Led Longevity and Anti-Ageing Skin Health Platform · theprint.in

A doctor in Mumbai wanted to help people take care of their skin in a smarter way.

His company is called Brilliance Cosmocare.

Instead of just selling creams or discount laser packages, the company checks your skin first with a special scan.

The scan looks at things like how old your skin seems, how hydrated it is, pigmentation, sun damage, and barrier health.

Then real doctors use that information to build a treatment plan just for you.

The company has helped more than 12,000 patients over ten years.

People like it a lot, giving it a 4.9-star rating from over 500 reviews.

Now the company received $200,000 from investors to grow bigger.

The money will help build new products and a special record system that tracks your skin over time.

The goal is to keep your skin healthy for a long time, not just fix problems quickly.

Key facts

Company
Brilliance Cosmocare
Funding
$200,000 (Rs 1.65 crore) seed round
Founders
Dr Ashok Patel (aesthetic surgeon) and Satyapal Chandra (technology entrepreneur)
Location
Mumbai, India; clinic in Andheri West
Patients treated
More than 12,000 over a decade
Patient rating
4.9 stars from over 500 verified reviews
India market size
Nearly $5 billion today, projected to cross $11 billion by 2032
Use of funds
Clinical infrastructure, preventive-care product development, Skin Record platform expansion

Quotes

Dr. Ashok Patel

Founder and Chief Medical Officer of Brilliance Cosmocare

“Most people think of anti-ageing as something you do at 45, in a hurry, after the damage is already visible. We think about it as skin health you build for a decade, diagnosed early, tracked over time, and treated only when there’s a real reason to. Beauty is a natural outcome of that. It was never meant to be the starting point.”
theprint.in

Sources

Related news